Effect of grapefruit juice on clarithromycin pharmacokinetics

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 4, 1998, Pages 927-929

  Cheng, Kit L ^a   Nafziger, Anne N ^a,b   Peloquin, Charles A ^c   Amsden, Guy W ^a,b  

^a BASSETT HEALTHCARE   (United States)

^b BASSETT RESEARCH INSTITUTE   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; CYCLOSPORIN; FELODIPINE; MACROLIDE;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; CITRUS FRUIT; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; FOOD DRUG INTERACTION; FRUIT JUICE; HAEMOPHILUS INFLUENZAE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NORMAL HUMAN; NOTE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0031968045     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.4.927     Document Type: Note

References (21)

1. Bailey, D. G., J. R. Bend, M. O. Arnold, L. T. Tran, and J. D. Spence. 1996. Erythromycin-felodipine interaction: magnitude, mechanism, and comparison with grapefruit juice. Clin. Pharmacol. Ther. 60:25-33.
2. Bailey, D. G., J. M. O. Arnold, and J. D. Spence. 1994. Grapefruit juice and drugs: how significant is the interaction? Clin. Pharmacokinet. 26:91-98.
3. Chu, S. Y., Y. Park, C. Locke, D. S. Wilson, and J. C. Cavanaugh. 1992. Drug-food interaction potential of clarithromycin, a new macrolide antimicrobial. J. Clin. Pharmacol. 32:32-36.
4. Chu, S. Y., L. T. Sennello, S. T. Bunnell, L. L. Varga, D. S. Wilson, and R. C. Sonders. 1992. Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses. Antimicrob. Agents Chemother. 36:2447-2453.
5. Cockroft, D. W., and M. H. Gault. 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41.
6. Daniel, W. W. 1987. Biostatistics: a foundation for analysis in the health sciences, 4th ed. John Wiley & Sons, New York, N.Y.
7. Ducharme, M. P., L. H. Warbasse, and D. J. Edwards. 1995. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin. Pharmacol. Ther. 57:485-491.
8. Edwards, D. J., F. H. Bellevue III, and P. M. Woster. 1996. Identification of 6′,7′-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metab. Dispos. 24:1287-1290.
9. Fass, R. J. 1993. Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. Antimicrob. Agents Chemother. 37:2080-2086.
10. Fraschini, F. F. Scaglione, and G. Demartini. 1993. Clarithromycin clinical pharmacokinetics. Clin. Pharmacokinet. 25:189-204.
11. Fuhr, U., and A. L. Kummert. 1995. The fate of naringin in humans: a key to grapefruit juice-drug interactions? Clin. Pharmacol. Ther. 58:365-373.
12. Hollander, A. A. M. J., J. Rooij, E. G. W. M. Lentjes, F. Arbouw, J. B. Bree, R. C. Schoemaker, L. A. Es, F. J. Woude, and A. F. Cohen. 1995. The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients. Clin. Pharmacol. Ther. 57:318-324.
13. Honig, P. K., D. C. Wortham, A. Lazarev, and L. R. Cantilena. 1996. Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine. J. Clin. Pharmacol. 36:345-351.
14. Hukkinen, S. K., A. Varhe, K. T. Olkkola, and P. J. Neuvonen. 1995. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clin. Pharmacol. Ther. 58:127-131.
15. Kupferschmidt, H. H. T., H. R. Ha, W. H. Ziegler, P. J. Meier, and S. Krahenbuhl. 1995. Interaction between grapefruit juice and midazolam in humans. Clin. Pharmacol. Ther. 58:20-28.
16. Lundahl, J., C. G. Regardh, B. Edgar, and G. Johnsson. 1995. Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects. Eur. J. Clin. Pharmacol. 49:61-67.
17. Min, D. I., Y. M. Ku, D. R. Geraets, and H. C. Lee. 1996. Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers. J. Clin. Pharmacol. 36:469-476.
18. Sturgill, M. G., and R. P. Rapp. 1992. Clarithromycin: review of a new macrolide antibiotic with improved microbiologic spectrum and favorable pharmacokinetic and adverse effect profiles. Ann. Pharmacother. 26:1099-1108.
19. Tanswell, P., and J. Koup. 1993. TopFit: a PC based pharmacokinetic/ pharmacodynamic data analysis program. Int. J. Clin. Pharmacol. Ther. Toxicol. 31:514-520.
20. Vanakowski, J., M. J. Mattila, and T. Seppala. 1996. Grapefruit juice does not enhance the effects of midazolam and triazolam in man. Eur. J. Clin. Pharmacol. 50:501-508.
21. Vincent, J., G. Foulds, L. C. Dogolo, S. A. Willavize, and H. L. Friedman. 1996. Grapefruit juice does not alter the pharmacokinetics of amlodipine in man. American Society for Clin. Pharmacol. and Ther. 61:233.